Literature DB >> 11331273

Smad proteins suppress CCAAT/enhancer-binding protein (C/EBP) beta- and STAT3-mediated transcriptional activation of the haptoglobin promoter.

A Zauberman1, S Lapter, D Zipori.   

Abstract

Activin A, a member of the transforming growth factor beta (TGFbeta) superfamily, blocks interleukin (IL)-6 biological functions. The molecular basis of the influence of this TGFbeta signaling on the IL-6 receptor triggered cascade is unknown. We studied IL-6-induced secretion of the acute phase protein haptoglobin by hepatoma cells. Overexpression of the C/EBPbeta gene, a downstream effector in the IL-6 pathway, activated transcription from the haptoglobin promoter. This was abolished by either a constitutively active form of activin A type IB receptor (CAactRIB) or by a combination of Smad3 and Smad4. Similarly, Smads abolished transcriptional activation by co-stimulation with IL-6 and STAT3. The transcription co-activator p300 partially overcame the suppressive effect of Smads. Electrophoretic mobility shift assays indicated that C/EBPbeta binding to haptoglobin promoter DNA was reduced by over-expression of CAactRIB and Smad4. We thus show that Smad proteins operate as transcription inhibitors on target genes of the IL-6 induced pathway. The effect of Smads is exerted on components of the transcription activation complex and may also involve interference with DNA binding. This study thus depicts molecular sites of interaction between the TGFbeta superfamily and the IL-6 signaling cascades.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11331273     DOI: 10.1074/jbc.M005813200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  16 in total

1.  TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3.

Authors:  D Liu; B L Black; R Derynck
Journal:  Genes Dev       Date:  2001-11-15       Impact factor: 11.361

2.  Transcription factor Smad3 is required for the inhibition of adipogenesis by retinoic acid.

Authors:  François Marchildon; Catherine St-Louis; Rahima Akter; Victoria Roodman; Nadine L Wiper-Bergeron
Journal:  J Biol Chem       Date:  2010-02-23       Impact factor: 5.157

3.  Transforming Growth Factor-β (TGF-β) Directly Activates the JAK1-STAT3 Axis to Induce Hepatic Fibrosis in Coordination with the SMAD Pathway.

Authors:  Liu-Ya Tang; Mary Heller; Zhaojing Meng; Li-Rong Yu; Yi Tang; Ming Zhou; Ying E Zhang
Journal:  J Biol Chem       Date:  2017-01-31       Impact factor: 5.157

4.  Smad7 enables STAT3 activation and promotes pluripotency independent of TGF-β signaling.

Authors:  Yi Yu; Shuchen Gu; Wenjian Li; Chuang Sun; Fenfang Chen; Mu Xiao; Lei Wang; Dewei Xu; Ye Li; Chen Ding; Zongping Xia; Yi Li; Sheng Ye; Pinglong Xu; Bin Zhao; Jun Qin; Ye-Guang Chen; Xia Lin; Xin-Hua Feng
Journal:  Proc Natl Acad Sci U S A       Date:  2017-09-05       Impact factor: 11.205

5.  Interaction of Yersinia pestis with macrophages: limitations in YopJ-dependent apoptosis.

Authors:  Ayelet Zauberman; Sara Cohen; Emanuelle Mamroud; Yehuda Flashner; Avital Tidhar; Raphael Ber; Eytan Elhanany; Avigdor Shafferman; Baruch Velan
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

6.  Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype.

Authors:  Leopoldo N Segal; Jose C Clemente; Jun-Chieh J Tsay; Sergei B Koralov; Brian C Keller; Benjamin G Wu; Yonghua Li; Nan Shen; Elodie Ghedin; Alison Morris; Phillip Diaz; Laurence Huang; William R Wikoff; Carles Ubeda; Alejandro Artacho; William N Rom; Daniel H Sterman; Ronald G Collman; Martin J Blaser; Michael D Weiden
Journal:  Nat Microbiol       Date:  2016-04-04       Impact factor: 17.745

7.  Evidence for activation of the TGF-beta1 promoter by C/EBPbeta and its modulation by Smads.

Authors:  Selvajothi Abraham; Thersa Sweet; Kamel Khalili; Bassel E Sawaya; Shohreh Amini
Journal:  J Interferon Cytokine Res       Date:  2009-01       Impact factor: 2.607

8.  IL-37 is a fundamental inhibitor of innate immunity.

Authors:  Marcel F Nold; Claudia A Nold-Petry; Jarod A Zepp; Brent E Palmer; Philip Bufler; Charles A Dinarello
Journal:  Nat Immunol       Date:  2010-10-10       Impact factor: 25.606

9.  Activatin' human adipose progenitors in obesity.

Authors:  Jaswinder K Sethi
Journal:  Diabetes       Date:  2010-10       Impact factor: 9.461

10.  Luteolin triggers global changes in the microglial transcriptome leading to a unique anti-inflammatory and neuroprotective phenotype.

Authors:  Konstantin Dirscherl; Marcus Karlstetter; Stefanie Ebert; Dominik Kraus; Julia Hlawatsch; Yana Walczak; Christoph Moehle; Rudolf Fuchshofer; Thomas Langmann
Journal:  J Neuroinflammation       Date:  2010-01-14       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.